drugset / Trial / NCT00729794

Vasopressin, Epinephrine, and Steroids for Cardiac Arrest

NCT00729794

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The simultaneous activation of adrenergic and vasopressin receptors, in conjunction with a potential steroid-mediated enhancement of the vascular reactivity to epinephrine may have beneficial effects in patients with cardiac arrest. This hypothesis is supported by the single-center results of NCT 00411879. The investigators intend to either refute or provide definitive evidence supporting this hypothesis (and its generalizability) by conducting the present multicenter, randomized, controlled clinical trial of in hospital cardiac arrest.

Timeline

Start
2008-09
Primary completion
2010-11
Completion
2010-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 300 mg
Subject Methylprednisolone Other / unclassified 40 mg
Subject Vasopressin Peptide 20 iu
Comparator Epinephrine Other / unclassified 1 mg

Indications